Last verified: April 2026
The 28-Day Caps
Possession and purchase limits live in §26B-4-245 (formerly §26-61a-201). Each cardholder may possess or purchase, in any 28-day rolling window:
- 113 grams (~4 oz) of unprocessed cannabis flower, AND
- 20 grams of composite THC across all other (processed) products combined
Tracking is enforced through the Electronic Verification System (EVS) and pharmacy point-of-sale integration. The pharmacy’s POS will not complete a transaction that would put a patient over either cap.
Approved Dosage Forms
Utah’s list of legal dosage forms is exhaustive — anything not on this list is prohibited:
- Tablets
- Capsules
- Concentrated oil
- Tinctures (liquid suspension)
- Topicals (creams, balms)
- Transdermal preparations (patches)
- Sublingual preparations
- Gelatinous cubes or rectangular lozenges (the only edible forms)
- Blister-packed flower – sealed pods of one gram or less, individually barcoded after December 31, 2020, for vaporization only
- Wax, resin, or concentrate — only available after a provider documents that two other forms have failed
- Aerosol — added by SB 190 (2022); not widely commercialized
The Gelatinous-Cube Rule
Utah’s edible rule is unique among legal medical states. Edibles must be cube-shaped or rectangular — nothing else. The following are explicitly prohibited:
- Brownies, cookies, baked goods of any kind
- Gummies shaped like fruit, animals, or characters
- Chocolates of any shape
- Infused beverages
- Hard candies, lollipops, or sugar candies
Approved products are typically cube-shaped gummies or rectangular lozenges at 10 mg THC per serving. The shape rule reflects the 2018 negotiated concession to Drug Safe Utah, which argued that fun-shaped edibles encourage youth use.
A medical cannabis product may only be in a medicinal dosage form. A medicinal dosage form does not include a candy, brownie, cookie, or other product that is or may be appealing to a minor.
Utah Code §26B-4-202 — Approved Dosage Forms
Smokable Flower — Vaporization Only
Utah permits flower but prohibits combustion. Patients may purchase flower, but only in sealed blister packs of one gram or less per pod, individually barcoded for dose-specific tracking. Pharmacies sell vaporizer hardware alongside flower; there are no pre-rolls and no loose flower.
Advocates including the Utah Patients Coalition argue the blister-pack requirement damages trichomes during the packaging process and inflates patient cost. The legislature has so far declined to revisit the rule.
Labeling and Packaging Rules
Labeling lives at §4-41a-602 and rule R66-2-13. Every product must:
- Carry a barcode tied to UDAF inventory control
- Be packaged in opaque and child-resistant containers
- List cannabinoid content (THC, CBD, etc.) and total weight
- Include the warning: “KEEP OUT OF REACH OF CHILDREN. This product is for medical use only.”
SB 64 (2025) added a patient product information insert effective May 2025 — pharmacy-issued documentation accompanying each transaction. SB 121 (2026) added new label warnings on addiction risk, mental-illness interactions, and use during pregnancy.
What Patients Actually Buy — Vapes Lead by Revenue
The product mix has shifted decisively in 2025–2026. Vape cartridges have overtaken flower as the leading category by revenue. January 2026 monthly sales by category:
| Category | January 2026 Revenue |
|---|---|
| Vape cartridges | ~$7.6M |
| Flower (blister-packed) | ~$5.2M |
| Edibles (gelatinous cubes) | ~$2.8M |
| Topicals | ~$112K |
The patient-side picture is more complicated. A 2023 demand study found that roughly 59% of patient-side acquisitions still came from illicit sources — price, the gelatinous-cube restriction on edibles, and the blister-pack requirement on flower remain the main drivers.
Why the Restrictions Matter
The shape rule, the blister-pack rule, the no-combustion rule, and the “wax/resin only after documented failure” rule together form a deliberately medical-flavored product regime. Each was a concession negotiated in October 2018 to win LDS Church and legislative leadership support for replacing Prop 2 with HB 3001. See Prop 2 vs HB 3001 for the full side-by-side.
Explore Related Topics
Official Sources
- Utah Code §26B-4-245 — Possession Limits
- Utah Code §26B-4-202 — Dosage Forms
- Utah Code Title 4, Chapter 41a — Cannabis Production
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org